
© 2025 sharedeals.de
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
10.04. | PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose | ||
09.04. | Phio Pharmaceuticals Corp. - 8-K, Current Report | ||
09.04. | Phio advances skin cancer treatment with successful trial | ||
09.04. | Phio erzielt Fortschritte bei Hautkrebsbehandlung mit erfolgreicher Studie | ||
09.04. | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort | Marlborough, Massachusetts--(Newsfile Corp. - April 9, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary... ► Artikel lesen |